Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY

William Hulme ,David Evans,Tom Ward,Chris Bates,Helen I Mcdonald,Simon Davy,Alex J Walker,Elsie Horne ,Ben Goldacre,Sebastian Bacon ,Amir Mehrkar,Krishnan Bhaskaran,Richard Croker,Amelia Green ,Laurie Tomlinson ,Jonathan A C Sterne,Peter Inglesby,Angel Wong ,Liam Smeeth,Jessica Morley,Ian Douglas ,Louis Fisher,Sam Harper,Christopher T Rentsch,Stephen Evans ,Daniel Grint ,Frank Hester,Jonathan Cockburn,Elizabeth Williamson ,Anna Schultze,Tom Palmer,Harriet Forbes,Rohini Mathur,Rosalind M Eggo,Caroline E Morton,Helen J Curtis,John Tazare,George Hickman,Miguel A Hernán ,Kevin Wing,Brian Mackenna,John Parry

doi:10.1136/bmj-2021-068946

Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY

William Hulme , David Evans + Show 40 more

Open Access

https://doi.org/10.1136/bmj-2021-068946

Copy DOI

Journal: BMJ (Clinical research ed.)	Publication Date: Jul 20, 2022
Citations: 16	License type: open-access

Affiliation: University of Oxford, University of London, London School of Hygiene & Tropical Medicine, NIHR Bristol Biomedical Research Centre, University of Bristol, Health Data Research UK, Harvard University

#Hospital Admission #Covid-19 Related Hospital + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveTo compare the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and the ChAdOx1 (Oxford-AstraZeneca) covid-19 vaccines against infection and covid-19 disease in health and social care workers.DesignCohort study, emulating a comparative...

Full Text